Alborz Bejnood

1.9k citations
5 papers · 211 indexed · h-index 2
Topics
Cancer Immunotherapy and Biomarkers (3 papers)Immunotherapy and Immune Responses (2 papers)Cancer Genomics and Diagnostics (1 paper)
Journals
ScienceSHILAP Revista de lepidopterologíaCancer Research
Partner nations
United StatesIndiaCanada

In The Last Decade

Alborz Bejnood

5 papers receiving 210 citations

Peers

Alborz Bejnood
Comparison fields: 5 of 45
  • Molecular Biology 106
  • Pulmonary and Respiratory Medicine 102
  • Oncology 68
  • Cancer Research 60
  • Immunology 31
Replace Ojasvi Chaudhary with:
Ojasvi Chaudhary United States
Eliot Linton United States
Huadong Lai China
Pedro Oliveira United Kingdom
Yuman He China
Bao Chang United States
Sevilay Turan United States
Chun-Lin Lin United States
Jack Zhu United States
Alborz Bejnood relative to Ojasvi Chaudhary United States Ojasvi Chaudhary's profile →
Citations per field
00.5×1.5×
Ojasvi Chaudhary · 1×
Citations per year

Countries citing papers authored by Alborz Bejnood

Since Specialization
Citations

This map shows the geographic impact of Alborz Bejnood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alborz Bejnood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alborz Bejnood more than expected).

Fields of papers citing papers by Alborz Bejnood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alborz Bejnood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alborz Bejnood. The network helps show where Alborz Bejnood may publish in the future.

Co-authorship network of co-authors of Alborz Bejnood

This figure shows the co-authorship network connecting the top 25 collaborators of Alborz Bejnood. A scholar is included among the top collaborators of Alborz Bejnood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alborz Bejnood. Alborz Bejnood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 1
2 170
3 38
4 1
5 1

About Alborz Bejnood

Alborz Bejnood is a scholar working on Oncology, Immunology and Cancer Research, having authored 5 papers that have together received 211 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (60 citations), Pulmonary and Respiratory Medicine (102 citations) and Oncology (68 citations). Alborz Bejnood has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Dana Pe’er, Anuradha Gopalan, Danielle Choi, Ojasvi Chaudhary, Moshe Biton, Katia Manova, Vincent P. Laudone, Brett F. Carver, Tianhao Xu and Wouter R. Karthaus. Their work appears in journals such as Science, SHILAP Revista de lepidopterología and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026